尿液奥尔法托美丁4预测了重症儿童的罗塞米德反应和脏替代疗法
Denise C Hasson1, Imogen Clover-Brown2, Diana Zepeda-Orozco3,4
1Division of Pediatric Critical Care Medicine, NYU Langone Health, Hassenfeld Children's Hospital, New York, NY.
Critical care explorations
|December 3, 2025
概括
尿液奥尔法托美丁4 (uOLFM4) 显示适度的能力,预测furosemide响应和脏替代疗法 (KRT) 在重症儿童. 凭借高负预测值,uOLFM4有助于早期的KRT决策.
科学领域:
- 儿科重症监护医药 儿科重症监护医药
- 腎臟醫學 腎臟醫學
- 发现生物标志物的发现.
背景情况:
- 急性损伤 (AKI) 是儿科重症监护室 (PICU) 的一个重大问题.
- 早期识别那些不会对利剂 (如罗西米德) 产生反应的患者对于及时干预至关重要.
- 需要预测AKI进展和治疗反应的生物标志物.
研究的目的:
- 评价尿液奥尔法托美丁4 (uOLFM4) 作为高风险儿科AKI患者罗塞米德反应的预测指标.
- 评估uOLFM4能够预测需要替代疗法 (KRT) 的能力.
主要方法:
- 在两个四级护理 PICU 进行前性观察队列研究.
- 包括240名患有高性心痛指数的儿科患者.
- 在PICU0-1天测量了uOLFM4和尿中性粒细胞凝酶相关的脂卡林 (uNGAL).
主要成果:
- 在不对罗塞米德反应的患者和接受KRT的患者中观察到更高的uOLFM4和uNGAL水平.
- 这两种生物标志物都表现出适度的区分能力来预测罗西米德的反应 (uOLFM4的AUC:0.77).
- uOLFM4对罗塞米德反应的负预测值为95%.
结论:
- uOLFM4和uNGAL在预测重症儿童的罗塞米德反应和KRT接收方面具有中等效果.
- uOLFM4的高负预测值表明其在临床决策支持中对早期KRT启动的潜在实用性.
相关概念视频
Renal Failure: Dose Adjustments
407
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
407
Acute Kidney Injury V: Interprofessional Care
282
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
282
Acute Kidney Injury IV: Diagnostic Studies and Prevention
244
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
244
Factors Affecting Renal Clearance: Renal Impairment
402
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
402
Pharmacokinetics in Pediatric Patients: Drug Excretion
195
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
195
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
174
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
174


